Metformin, a widely used diabetes medication, can cause hidden vitamin B12 deficiency that damages nerves and the spinal cord, even when standard blood tests appear normal. According to Gram Research analysis of this 2026 case report, a 57-year-old man on metformin developed serious nerve damage and spinal cord problems despite having a normal B12 blood level—the deficiency was only discovered through additional testing showing extremely elevated homocysteine. High-dose B12 injections led to significant improvement, highlighting the importance of thorough B12 monitoring beyond routine blood tests for metformin users.
A 57-year-old man taking metformin for diabetes developed a rare but serious condition caused by vitamin B12 deficiency, even though his blood tests initially looked normal. According to Gram Research analysis, metformin can interfere with how the body absorbs B12 from food, leading to nerve damage and spinal cord problems. The patient experienced weakness, numbness, and balance problems before doctors discovered the real cause using advanced testing. This case report highlights why people on metformin need regular B12 monitoring and shows that normal B12 blood levels don’t always tell the whole story.
Key Statistics
A 2026 case report documented a 57-year-old man on metformin therapy who developed subacute combined degeneration of the spinal cord from vitamin B12 deficiency, despite having a normal serum B12 level that was only detected through elevated homocysteine testing.
Research shows that metformin-associated B12 deficiency can impair myelin formation in the spinal cord and peripheral nerves, leading to serious neurological complications including gait ataxia and sensory loss, as demonstrated in this patient who improved significantly with high-dose intramuscular B12 supplementation.
The case revealed that standard vitamin B12 blood tests can appear normal in metformin users with functional B12 deficiency, requiring additional metabolic evaluation such as homocysteine measurement to detect cellular-level B12 insufficiency.
The Quick Take
- What they studied: How metformin, a common diabetes medication, can cause hidden vitamin B12 deficiency that damages nerves and the spinal cord
- Who participated: One 57-year-old man with type 2 diabetes who had been taking metformin for one year
- Key finding: The patient had serious nerve and spinal cord damage from B12 deficiency despite having a normal B12 blood level, discovered through additional metabolic testing showing very high homocysteine levels
- What it means for you: If you take metformin for diabetes, ask your doctor about B12 monitoring beyond standard blood tests. Don’t assume normal B12 levels mean you’re protected—your doctor may need to check other markers like homocysteine to catch hidden deficiency early
The Research Details
This is a case report, which means doctors documented one patient’s medical journey in detail. The 57-year-old man came to the hospital with stomach problems (no appetite, vomiting, weight loss) and neurological symptoms (difficulty walking, numbness). Doctors performed a thorough investigation including blood tests, nerve function tests (electromyography), and spinal cord imaging (MRI) to understand what was happening.
The case is important because it shows a hidden danger: the patient’s standard vitamin B12 blood test came back normal, which would normally mean everything was fine. However, additional testing revealed extremely high homocysteine levels—a sign that his cells weren’t getting enough B12 even though the blood level appeared adequate. This distinction is crucial because it means some people on metformin can develop B12 problems that standard tests miss.
After diagnosis, the patient received high-dose B12 injections and improved significantly over the following weeks. This positive response confirmed the diagnosis and showed that catching the problem early enough allows for recovery.
This research approach matters because it reveals a real-world gap in how doctors monitor diabetes patients. Metformin is one of the most prescribed diabetes medications worldwide, affecting millions of people. If doctors only rely on standard B12 blood tests, they could miss dangerous deficiencies in some patients. The case demonstrates that we need better screening methods and more awareness among healthcare providers about this specific risk.
As a case report of a single patient, this study provides detailed clinical information but cannot prove that metformin causes B12 deficiency in everyone who takes it. However, the thorough documentation, multiple diagnostic tests, and positive response to treatment make this a credible warning sign. The findings align with existing medical knowledge about how metformin affects B12 absorption. Doctors should use this case to inform their monitoring practices, but individual experiences may vary.
What the Results Show
The patient presented with four main problems: loss of appetite, vomiting, significant weight loss, and difficulty walking with poor balance (called gait ataxia). Physical examination showed numbness in the lower back and abdomen area, and weak reflexes in both legs. These symptoms pointed to nerve and spinal cord damage.
The critical finding was the disconnect between standard and advanced testing. The patient’s serum vitamin B12 level was normal—a result that would typically reassure both doctor and patient. However, when doctors measured homocysteine (a substance that builds up when B12 is low at the cellular level), they found it was substantially elevated. This indicated that despite adequate B12 in the bloodstream, the patient’s cells weren’t using it properly.
Nerve function testing (electromyography) confirmed damage to both motor and sensory nerves in the right arm. Spinal cord imaging showed the characteristic pattern of B12 deficiency damage in the dorsal columns (the back part of the spinal cord). All evidence pointed to metformin-associated B12 deficiency causing subacute combined degeneration—a serious condition affecting nerve function.
After starting high-dose intramuscular B12 injections, the patient showed clinically significant improvement within weeks. This positive response to treatment confirmed the diagnosis and demonstrated that early intervention can reverse some of the damage.
The case revealed that diabetic neuropathy (nerve damage from diabetes itself) and metformin-associated B12 deficiency can occur together, making diagnosis more challenging. The gastrointestinal symptoms (vomiting, weight loss, loss of appetite) may have been both a symptom of B12 deficiency and a sign that the absorption problem was severe. The patient’s one-year history on metformin suggests the deficiency developed relatively quickly, though individual timelines likely vary.
Medical literature has documented metformin-associated B12 deficiency for years, but this case adds important details about how it can progress to serious spinal cord damage. Previous research showed that 10-30% of long-term metformin users develop low B12 levels, but most don’t develop symptoms. This case demonstrates that some patients progress to severe neurological complications, highlighting why monitoring matters. The finding that standard B12 blood tests can be normal while cellular B12 deficiency exists confirms what some researchers have suspected: we need better screening methods.
This is a single case report, so we cannot determine how common this problem is or predict who will develop it. The patient’s specific health history, genetics, and diet may have contributed to his severe outcome—other metformin users might not progress the same way. The case doesn’t prove that metformin caused the B12 deficiency in this specific patient, though the timeline and medical evidence strongly suggest it. Additionally, we don’t know long-term outcomes beyond the initial improvement with treatment. Doctors should use this case as a warning sign to monitor patients more carefully, but individual risk varies.
The Bottom Line
If you take metformin: (1) Ask your doctor about B12 monitoring—don’t assume normal blood tests are sufficient; (2) Discuss checking homocysteine levels or other markers of cellular B12 status; (3) Watch for warning signs like numbness, tingling, balance problems, or persistent stomach issues; (4) Consider B12 supplementation if your doctor recommends it, even if blood levels appear normal. Confidence level: Moderate to High—this case combined with existing research supports proactive monitoring.
Anyone taking metformin for type 2 diabetes should be aware of this risk, especially those on long-term therapy (over one year). People with existing nerve problems, stomach issues, or family history of B12 deficiency should be particularly vigilant. Healthcare providers should use this case to inform their monitoring practices. People not on metformin don’t need to worry about this specific risk, though B12 deficiency from other causes remains possible.
B12 deficiency can develop gradually over months to years on metformin, but serious symptoms may appear suddenly. In this case, one year of metformin therapy led to severe spinal cord damage. However, most metformin users don’t develop symptoms. With early detection and B12 supplementation, improvement can occur within weeks to months. Waiting for symptoms to appear risks permanent nerve damage, so proactive monitoring is essential.
Frequently Asked Questions
Can metformin cause vitamin B12 deficiency?
Yes. Metformin interferes with how the body absorbs B12 from food in the stomach and intestines. A 2026 case report documented a patient who developed serious nerve and spinal cord damage from metformin-associated B12 deficiency after one year of therapy, even with a normal B12 blood level.
What are the symptoms of B12 deficiency from metformin?
Symptoms include numbness and tingling in hands or feet, balance problems, weakness, difficulty walking, loss of appetite, nausea, and vomiting. The 2026 case showed that serious spinal cord damage can develop before symptoms become obvious, making early detection through blood tests crucial.
How often should I get B12 tested if I take metformin?
Ask your doctor about testing every 6-12 months, especially after one year of metformin use. Standard B12 blood tests may not catch all cases—your doctor should also consider checking homocysteine levels or other markers of cellular B12 status for complete assessment.
Can B12 deficiency from metformin be reversed?
Yes, if caught early. The 2026 case report showed that high-dose B12 injections led to clinically significant improvement within weeks. However, waiting too long risks permanent nerve damage, so proactive monitoring and early treatment are essential.
Does everyone on metformin develop B12 deficiency?
No. Research suggests 10-30% of long-term metformin users develop low B12 levels, but most don’t develop symptoms. However, some patients like the one in this 2026 case report can progress to serious complications, making individual monitoring important.
Want to Apply This Research?
- Log metformin doses and dates, then track B12 lab results (serum B12, homocysteine levels, methylmalonic acid) every 6-12 months. Record any neurological symptoms: numbness, tingling, balance problems, or weakness. Note stomach symptoms: appetite changes, nausea, or vomiting. This creates a timeline to share with your doctor.
- Set a quarterly reminder to ask your doctor about B12 status. If prescribed B12 supplements or injections, use the app to track doses and any symptom improvements. Log dietary B12 sources (meat, dairy, fortified foods) to monitor intake. Report new neurological symptoms immediately rather than waiting for scheduled appointments.
- Create a long-term health dashboard tracking: (1) Metformin dosage and duration; (2) B12 lab results with dates; (3) Homocysteine levels if available; (4) Neurological symptoms with severity ratings; (5) B12 supplementation schedule. Review this dashboard during doctor visits to ensure adequate monitoring. Alert users to seek immediate care if they develop new numbness, tingling, or balance problems.
This article describes a single case report and should not be interpreted as medical advice. Metformin-associated B12 deficiency is a recognized but uncommon complication. If you take metformin and experience numbness, tingling, balance problems, or other neurological symptoms, contact your healthcare provider immediately. Do not start, stop, or change any medication without consulting your doctor. This information is for educational purposes and does not replace professional medical evaluation, diagnosis, or treatment. Individual responses to metformin vary, and your doctor can assess your personal risk factors and recommend appropriate monitoring.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.